FDA Grants 510(k) Clearance for Pulmera’s CBeam™ 3D Imaging Platform (opens in new tab)

Palo Alto, CA, June 02, 2026 (GLOBE NEWSWIRE) — Pulmera, an emerging medical technology company developing next-generation intraoperative imaging solutions, today announced that it has received U.S. Food and Drug Administration 510(k) clearance for its CBeam™ 3D imaging platform. CBeam is designed to transform conventional 2D surgical C-arms into intraoperative 3D imaging systems, helping surgical […] The post appeared first on <a href="